Shenzhen Neptunus Interlong Bio-technique Company Limited (8329) has scheduled an extraordinary general meeting (EGM) at 10:00 a.m. on Tuesday, 23 December 2025, to be held at the 24th Floor of Neptunus Yinhe Technology Mansion in Nanshan District, Shenzhen. The meeting aims to review and vote on the new Neptunus Group Sales Framework Agreement dated 30 October 2025 with Shenzhen Neptunus Group Company Limited.

The agreement covers the sale of various self-manufactured or distributed products, including pharmaceutical products, healthcare food, and medical devices. Proposed sales caps for 2026, 2027, and 2028 will be presented for confirmation. The EGM will also consider authorizing a director to finalize and execute any additional documents or amendments related to the agreement.

Interested shareholders, both holders of H shares and domestic shares, may attend and vote during the EGM subject to the applicable proxy and attendance procedures detailed in the official announcement. The final outcome of the proposed agreement and sales caps will be determined based on shareholder votes at the meeting.